# Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery

> **NCT00922597** · — · COMPLETED · sponsor: **Bayer** · enrollment: 26 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** Recombinant Factor VIII (Kogenate FS, BAY14-2222)

## Key facts

- **NCT ID:** NCT00922597
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** —
- **Final completion:** 2011-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922597, "Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00922597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*